Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes

Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes

Abstract Arathi Srinivasan Aims The aim was to study cytogenetics and molecular genetic profile in pediatric B-acute lymphoblastic leukemia (ALL) and correlate it with induction outcomes....

Full description

Bibliographic Details
Main Authors:	Ajeitha Loganathan, Rishab Bharadwaj, Arathi Srinivasan, Julius Xavier Scott
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-10-01
Series:	South Asian Journal of Cancer
Subjects:	acute lymphoblastic leukemia cytogenetics induction minimal residual disease pediatric
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1754337

Similar Items

Molecular Cytogenetic Study in Patients with Acute Lymphoblastic Leukemia (ALL) in Erbil Province
by: Heveen Omar Hassan, et al.
Published: (2021-06-01)

Immunophenotypic and cytogenetic characteristics of pediatric acute lymphoblastic leukemia: A burden estimation study from Eastern India
by: Subhajit Dey Sarkar, et al.
Published: (2024-01-01)

Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia
by: A. N. Vasileva, et al.
Published: (2024-04-01)

Association of cytogenetics and immunophenotype in prognosis of children with acute lymphoblastic leukemia: Literature Review
by: Abdollah Banihashem, et al.
Published: (2014-02-01)

Association of cytogenetics and immunophenotype in prognosis of children with acute lymphoblastic leukemia: Literature Review
by: Abdollah Banihashem, et al.
Published: (2014-02-01)

Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia
by: Rachana Chennamaneni, et al.
Published: (2018-01-01)

A retrospective cytogenetic abnormality in pediatric acute lymphoblastic leukemia: Report of 11 years
by: Kazem Ghaffari, et al.
Published: (2022-01-01)

Cytogenetic Findings of Patients with Acute Lymphoblastic Leukemia in Fars Province
by: Akbar Safaei, et al.
Published: (2013-12-01)

A Retrospective Survey of Molecular, Cytogenetic, and Immunophenotype Data of Patients with Acute Lymphoblastic Leukemia in Northeast Iran
by: Seyyede Fatemeh Shams, et al.
Published: (2019-07-01)

Molecular Cytogenetic Study in Patients with Acute Lymphoblastic Leukemia (ALL) in Erbil Province
by: Heveen Omar Hassan, et al.
Published: (2021-06-01)

Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy
by: Jae-Ho Yoon, et al.
Published: (2024-01-01)

Acute Ph-negative lymphoblastic leukemias in adults: Risk factors in the use of the ALL-2009 protocol
by: E N Parovichnikova, et al.
Published: (2016-07-01)

Microbiological profile and outcomes of infections during induction therapy in childhood acute lymphoblastic leukemia
by: Ajeitha Loganathan, et al.
Published: (2017-01-01)

Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease
by: M. A. Shervashidze, et al.
Published: (2020-10-01)

Childhood B-lymphoblastic leukemia: Integrating cytogenetics with other prognostic parameters and correlation with post-induction remission
by: Neelum Mansoor, et al.
Published: (2023-09-01)

Assessment of minimal residual disease in childhood acute lymphoblastic leukemia
by: Sonia K Parikh, et al.
Published: (2016-01-01)

Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non‐high‐risk acute lymphoblastic leukemia treated according to the ALL‐MB 2008 protocol
by: Alexander Popov, et al.
Published: (2024-04-01)

Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial
by: O. A. Aleshina, et al.
Published: (2023-03-01)

Cytogenetic aberrations in adult acute lymphoblastic leukemia—A population‐based study
by: Emma Bergfelt Lennmyr, et al.
Published: (2021-11-01)

All about blinatumomab: the bispecific T cell engager immunotherapy for B cell acute lymphoblastic leukemia
by: Reza Mirfakhraie, et al.
Published: (2024-04-01)

IMMUNOLOGICAL CLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIAS
by: Samo Zver, et al.
Published: (2002-05-01)

Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia
by: Kyung Nam Koh, et al.
Published: (2010-11-01)

Differences in induction phase outcomes of acute lymphoblastic leukemia between well-nourished and malnourished pediatric patients
by: Meilani Puspasari Simarmata, et al.
Published: (2023-06-01)

PROGNOSTIC SIGNIFICANCE AND TREATMENT IMPLICATIONS OF MINIMAL RESIDUAL DISEASE STUDIES IN PHILADELPHIA-NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
by: Orietta Spinelli, et al.
Published: (2014-08-01)

Flow cytometric minimal residual disease monitoring in children with acute lymphoblastic leukemia treated by regimens with reduced intensity
by: A. M. Popov, et al.
Published: (2015-12-01)

Leukemia-associated immunophenotype of tumor cells in childhood B-precursors acute lymphoblastic leukemia
by: L. V. Movchan
Published: (2014-07-01)

Leukemia-associated immunophenotype of tumor cells in childhood B-precursors acute lymphoblastic leukemia
by: L. V. Movchan
Published: (2014-07-01)

t(1;4) translocation in a child with acute lymphoblastic leukemia: a case report
by: Chaimae El Mahdaoui, et al.
Published: (2023-12-01)

CDX2 gene expression in acute lymphoblastic leukemia
by: Hanaa H. Arnaoaut, et al.
Published: (2014-06-01)

Expression of CD73 on leukemic blasts increases during follow-up – a promising candidate marker for minimal residual disease detection in pediatric B-cell precursor acute lymphoblastic leukemia
by: Łukasz Słota, et al.
Published: (2022-03-01)

Adult B-cell acute lymphoblastic leukemias: Conclusions of the Russian prospective multicenter study ALL-2009
by: E N Parovichnikova, et al.
Published: (2017-07-01)

Genetic Susceptibility and Treatment Personalization in Acute Lymphoblastic Leukemia: A Comprehensive Review of Genetic Susceptibility and Targeted Therapies
by: Nikita Nirmalkar, et al.
Published: (2024-09-01)

Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemia
by: Kenneth F. Bradstock, et al.
Published: (2016-12-01)

Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation
by: Maura R.V. Ikoma-Colturato, et al.
Published: (2021-07-01)

Pancytopenia - (?) An obstacle in the diagnosis and outcome of pediatric acute lymphoblastic leukemia
by: Shruti Raja, et al.
Published: (2015-01-01)

Outcome of neutropenic enteropathy during induction phase of treatment of childhood acute lymphoblastic leukemia
by: Yesmin Tanjin Jahan, et al.
Published: (2023-12-01)

Serum lactate dehydrogenase level in childhood acute lymphoblastic leukemia
by: Shaimaa Saad Abdul Zahra, et al.
Published: (2021-01-01)

Nutritional profile of children with acute Lymphoblastic Leukemia- data from a tertiary care centre from south India
by: Nuthan Kumar, et al.
Published: (2017-01-01)

Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
by: Andrea Rzepiel, et al.
Published: (2019-11-01)

Acute non-lymphoblastic leukemia: characteristics of cytogenetic anomalies and their influence on clinical course of the disease
by: A. M. Vakulchuk, et al.
Published: (2022-11-01)